Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 6.73 Billion | 6 Billion | 6.15 Billion | 5.9 Billion | 6.76 Billion | 6.78 Billion |
| Cost of Revenue | 2.83 Billion | 2.44 Billion | 2.18 Billion | 2.04 Billion | 1.7 Billion | 1.55 Billion |
| Gross Profit | 3.89 Billion | 3.55 Billion | 3.96 Billion | 3.86 Billion | 5.05 Billion | 5.23 Billion |
| Operating Expenses | 3.14 Billion | 2.76 Billion | 3.08 Billion | 3.1 Billion | 4 Billion | 4.07 Billion |
| Selling, General and Administrative Expenses | 2.4 Billion | 2.17 Billion | 2.51 Billion | 2.58 Billion | 3.47 Billion | 3.53 Billion |
| Research and Development Expenses | 298.09 Million | 195.71 Million | 197.44 Million | 184.98 Million | 183.01 Million | 183.38 Million |
| Other Expenses | -22.42 Million | 388.25 Million | 379.41 Million | 341.41 Million | 338.71 Million | 69.94 Million |
| Cost and Expenses | 5.94 Billion | 5.2 Billion | 5.27 Billion | 5.15 Billion | 5.7 Billion | 5.62 Billion |
| Operating Income | 788.26 Million | 880.17 Million | 3.47 Billion | 1.1 Billion | 951.49 Million | 1.02 Billion |
| Interest Expense | 37.43 Million | 49.47 Million | 72.97 Million | 123.64 Million | 151.22 Million | 95.17 Million |
| Income Tax Expense | 92.96 Million | 129.91 Million | 391.1 Million | 216.44 Million | 221.5 Million | 208.82 Million |
| Earnings before Tax | 767.69 Million | 590 Million | 2.51 Billion | 765.64 Million | -50.01 Million | 1.01 Billion |
| Net Income | 591.57 Million | 358.11 Million | 2.01 Billion | 453.3 Million | -271.51 Million | 803.79 Million |
| Earnings Per Share Basic | 0.23 | 0.14 | 0.79 | 0.18 | -0.10 | 0.31 |
| Earnings Per Share Diluted | 0.23 | 0.14 | 0.79 | 0.18 | -0.10 | 0.31 |
| Weighted Average Shares Outstanding | 2.57 Billion | 2.57 Billion | 2.57 Billion | 2.51 Billion | 2.65 Billion | 2.62 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.57 Billion | 2.57 Billion | 2.57 Billion | 2.51 Billion | 2.65 Billion | 2.62 Billion |
| Gross Margin | 0.58 | 0.59 | 0.64 | 0.65 | 0.75 | 0.77 |
| EBIT Margin | 0.17 | 0.19 | 0.61 | 0.23 | 0.18 | 0.21 |
| Profit Margin | 0.09 | 0.06 | 0.33 | 0.08 | -0.04 | 0.12 |
| EBITDA | 1.12 Billion | 916.96 Million | 2.88 Billion | 1.23 Billion | 490.95 Million | 1.37 Billion |
| Earnings Before Tax Margin | 0.12 | 0.15 | 0.56 | 0.19 | 0.14 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.46 Billion | 1.6 Billion | 1.82 Billion | 6.73 Billion | 1.54 Billion | 1.41 Billion |
| Cost of Revenue | 715.91 Million | 804.02 Million | 784.25 Million | 2.79 Billion | 779.49 Million | 606.94 Million |
| Gross Profit | 748.63 Million | 804.67 Million | 1.03 Billion | 3.93 Billion | 769.03 Million | 812.77 Million |
| Operating Expenses | 625.79 Million | 667.04 Million | 784.31 Million | 3.08 Billion | 700.12 Million | 658.07 Million |
| Selling, General and Administrative Expenses | 1.08 Billion | 601.63 Million | 716.21 Million | - | 151.98 Million | 800.69 Million |
| Research and Development Expenses | 74.72 Million | 65.55 Million | 59.37 Million | - | 133.75 Million | 71.21 Million |
| Other Expenses | -531.56 Million | 145.09 Thousand | -875.92 Thousand | -20.57 Million | -8.96 Million | -424.17 Thousand |
| Cost and Expenses | 1.34 Billion | 1.47 Billion | 1.56 Billion | 5.88 Billion | 1.47 Billion | 1.26 Billion |
| Operating Income | 170.78 Million | 137.63 Million | 270.26 Million | 788.26 Million | -17.55 Million | 152.21 Million |
| Interest Expense | 4.88 Million | 6.35 Million | 8.18 Million | 36.4 Million | 4.91 Million | 9.65 Million |
| Income Tax Expense | 26.35 Million | 35.73 Million | 39.42 Million | 92.96 Million | -1.35 Million | 27.54 Million |
| Earnings before Tax | 164.97 Million | 190.25 Million | 269.39 Million | 767.69 Million | -26.51 Million | 151.79 Million |
| Net Income | 136.25 Million | 166.13 Million | 216.06 Million | 591.57 Million | -31.66 Million | 107.1 Million |
| Earnings Per Share Basic | 0.05 | 0.07 | 0.08 | - | -0.01 | 0.04 |
| Earnings Per Share Diluted | 0.05 | 0.06 | 0.08 | - | -0.01 | 0.04 |
| Weighted Average Shares Outstanding | 2.5 Billion | 2.48 Billion | 2.57 Billion | 2.57 Billion | 2.58 Billion | 2.57 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.5 Billion | 2.63 Billion | 2.57 Billion | 2.57 Billion | 2.58 Billion | 2.57 Billion |
| Gross Margin | 0.51 | 0.50 | 0.57 | 0.58 | 0.50 | 0.57 |
| EBIT Margin | 0.12 | 0.14 | 0.16 | - | 0.04 | 0.13 |
| Profit Margin | 0.09 | 0.10 | 0.12 | 0.09 | -0.02 | 0.08 |
| EBITDA | 169.85 Million | 223.73 Million | 289.09 Million | - | 68.99 Million | 183.8 Million |
| Earnings Before Tax Margin | 0.12 | 0.09 | 0.15 | 0.12 | -0.01 | 0.11 |
2157
TPS
TIG
TPST
8957
ISUR